News
Our medical news may contain information about Shionogi products and is therefore intended for medical journalists and health care professionals only. By clicking through to see medical news, you are confirming that you are a medical journalist or healthcare professional.
October
12 Oct 2023
Release
Medical News
Shionogi Presents New Ensitrelvir COVID-19 Data Supporting Effectiveness in Real-World and Clinical Settings at IDWeek 2023
September
27 Sep 2023
Release
Medical News
Investigational Treatment for Fragile X Syndrome, Receives Rare Pediatric Disease Designation from the U.S. FDA
22 Sep 2023
Release
Medical News
Shionogi Presents New Ensitrelvir Clinical and Real-World Data Reinforcing Potential Across COVID-19 Populations at ESWI 2023
12 Sep 2023
Release
Medical News
Critical agreement paves way for new model to accelerate access to important antibiotics for serious bacterial infections
July
June
April
05 Apr 2023
Release
Medical News
Shionogi Receives U.S. FDA Fast Track Designation for Ensitrelvir Fumaric Acid, an Investigational Oral Antiviral for COVID-19
February
23 Feb 2023
Release
Medical News
Shionogi’s antibiotic, Fetcroja® (cefiderocol), is now available in the Netherlands
22 Feb 2023
Release
Medical News
Shionogi Presents Pivotal Ensitrelvir Fumaric Acid Phase 3 Data and Exploratory Long COVID Data at CROI
15 Feb 2023
Release
Medical News
Shionogi Advances Ensitrelvir Fumaric Acid COVID-19 Antiviral Clinical Program